| Literature DB >> 31057700 |
Antonios Athanasiou1, Mairead Hennessy2, Eleftherios Spartalis3, Benjamin H L Tan4, Ewen A Griffiths4.
Abstract
Esophageal conduit ischaemia and necrosis is an uncommon but devastating complication of esophagectomy and remains one of the most challenging issues in surgical practice. The incidence, time interval to develop symptoms, and clinical presentation are highly variable with no predictable pattern. Evidence comes from case reports and case series rather than randomized controlled trials. We describe the issues surrounding conduit necrosis affecting the stomach, jejunum and colon as an esophageal replacement and the advantages, disadvantages and challenges of each type of reconstruction. Diagnosis is challenging for the most experienced surgeon. Upper gastrointestinal endoscopy and computed tomography thorax with both oral and intravenous contrast is the gold standard. Management, either conservative or interventional is also a difficult decision. Management options include conservative treatment and more aggressive treatments such as stent insertion, surgical debridement and repair of the esophagus using jejunum, colon or a musculocutaneous flap. In spite of recent advances in surgical techniques, there is no reliable strategy to manage esophageal conduit necrosis. Our review covers the pathophysiology and clinical significance of esophageal necrosis while highlighting current techniques of prevention, diagnosis and treatment of this life-threatening condition.Entities:
Keywords: Esophageal cancers; Esophagectomy; Esophagogastric anastomosis
Year: 2019 PMID: 31057700 PMCID: PMC6478597 DOI: 10.4240/wjgs.v11.i3.155
Source DB: PubMed Journal: World J Gastrointest Surg
The Esophageal Complications Consensus Group definition and classification of conduit necrosis and ischemia[8]
| Type I: Conduit necrosis focal | Identified endoscopically | Additional monitoring or non-surgical therapy |
| Type II: Conduit necrosis focal | Identified endoscopically and not associated with free anastomotic or conduit leak | Surgical therapy not involving esophageal diversion |
| Type III: Conduit necrosis; extensive | Identified endoscopically | Treated with conduit resection with diversion |
Endoscopic classification system for the findings of gastric conduit ischaemia and necrosis[12]
| Grade 1 | Dusky bluish-color mucosa around the anastomosis covered with tenacious metallatic-appearing mucous that cannot be easily washout off |
| Grade 2 | Partial disruption of the anastomosis with equivocal viability of the adjacent mucosa or the normal pink mucosa margins |
| Grade 3 | Complete circumferential breakdown of the anastomosis with normal pink mucosa margins |
| Grade 4 | Completely necrotic black mucosa throughout the gastric conduit with the anastomosis still intact |
Figure 1Schematic diagram of procedural methodology.
Risk factors for gastric conduit necrosis
| Peripheral arterial disease | Twists in the gastric conduit | Post-operative hypotension and shock |
| Ischaemic heart disease | Tight hiatus | Vasoconstrictor use |
| Stenosis of the Coeliac trunk and Aorta[ | Injury to the gastro-epiploic vessels | |
| Cardiac failure/ impaired ejection fraction | Minimal access procedures[ | |
| Diabetes | Tacking sutures to the pre-vertebral fascia during transhiatal esophagectomy[ | |
| Tight thoracic inlet when a neck anastomosis is performed | ||
| Narrow gastric conduit |
Published Series of gastric ischaemic pre-conditioning prior to oesophagectomy in humans
| Ref. | ||||||
| Akiyama et al[ | Japan | Retrospective | 51 | 14 | Preoperative embolization of left gastric, right gastric, and splenic artery | PET is a safe procedure that contributes to the decrease in the frequency of anastomotic dehiscence after esophageal operation |
| Isomura et al[ | Japan | Retrospective | 37 | 14 | Preoperative embolization of left gastric, right gastric, and splenic artery | Reduction of postoperative anastomotic leakage in esophageal reconstruction |
| Nguyen et al[ | United States | Retrospective | 9 | 12 ± 10 | Ligation of left gastric vessels | There were no anastomotic leaks in the 9 patients |
| Veeramootoo et al[ | United Kingdom | Randomized controlled trial | 16 | 14 | Ligation of left gastric vessels | Laparoscopic ischemic conditioning does not translate into an improved perfusion of the gastric conduit tip |
| Wajed et al[ | United Kingdom | Retrospective | 67 | 14 | Ligation of left gastric vessels | 9 of them (13.4%) developed gastric conduit failure |
| Bludau et al[ | Germany | Prospective | 19 | 4-5 | Ligation of short gastric arteries and left gastric artery | Ischemic conditioning improves Mucosal oxygen saturation in the anastomotic region at the time of reconstruction |
| Holscher et al[ | Germany | Retrospective | 83 | 3-7 | Laparoscopic gastric devascularisation preserving right gastroepiploic arcade | Feasible and safe technique that may contribute to the reduction of postoperative morbidity and mortality after esophagectomy |
PET: Pre-operative embolization therapy.
Clinical studies for the evaluation of ischemic gastric conditioning using indocyanine green fluorescence imaging
| Kitagawa et al[ | 2017 | 72 | PDE | 2.5 mg | Retrospective | Intraoperative ICG assessment of the gastric tube was associated with postoperative endoscopic assessment grading of anastomosis during ER |
| Ohi et al[ | 2017 | 120 | PDE | 2.5 mg | Retrospective | ICG fluorescein imaging might decrease the incidence of anastomotic leak following ER |
| Koyanagi et al[ | 2016 | 40 | PDE | 2.5 or 1.25 mg | Prospective cohort | ICG fluorescence is a useful means to predict the risk of anastomotic leakage after ER |
| Yukaya et al[ | 2015 | 27 | Hyper Eye Medical System | 0.1 mg | Prospective cohort | ICG fluorescence can be used to quantitatively measure arterial blood flow and venous return of the reconstructed gastric tube in patients undergoing ER |
| Zehetner et al[ | 2015 | 150 | SPY Imaging System (Novadaq) | 2.5 mg | Prospective cohort | The use of laser-assisted fluorescent-dye angiography (LAA) may contribute to reduced anastomotic morbidity |
| Sarkariaet al[ | 2014 | 30 | NIFI technology | 10 mg | Prospective cohort | ICG fluorescence may be a useful adjunct during MIE gastric mobilization, especially early in the learning curve for these operations |
| Rino et al[ | 2014 | 33 | PDE | 2.5 mg | Prospective cohort | ICG fluorescence can be used to evaluate the blood supply to the reconstructed stomach in patients undergoing ER for esophageal cancer |
| Kumagai et al[ | 2014 | 20 | PDE | NA | Prospective cohort | ICG fluorescence method has potential usefulness for evaluation of blood flow in the gastric tube during ER |
| Pachecoet al[ | 2013 | 11 | SPY Imaging System (Novadaq) | NA | Retrospective | ICG fluorescence might be useful in patients undergoing ER |
| Murawaet al[ | 2012 | 15 | PDE | 2.5 mg | Prospective cohort | ICG fluorescence imaging allows for intraoperative modifications, but patient’s comorbidities and general health may also increase the risk of anastomosis leakage |
| Shimad et al[ | 2011 | 40 | PDE | 2.5 mg | Prospective cohort | The microcirculation detected by ICG fluorescence did not necessarily provide appropriate blood supply for a viable anastomosis |
ICG: Indocyanine green; ER: Esophageal resection; PDE: Hamamatsu Photonics K.K, Hamamatsu, Japan.